Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00HHU
|
|||
| Former ID |
DIB011858
|
|||
| Drug Name |
AFO-18
|
|||
| Synonyms |
Peptide vaccine (CAF-01 adjuvanted, HIV-1 infection), Statens Serum Institut
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1 | [1] | |
| Company |
Statens Serum Institut
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01009762) Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.